Welcome to our dedicated page for Nocopi Technolog SEC filings (Ticker: NNUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nocopi Technologies, Inc. (NNUP) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into how Nocopi, a developer of specialty reactive inks and authentication technologies, reports on its licensing agreements, product sales, capital structure and governance.
Through this page, users can review current and historical 10‑K and 10‑Q reports to see how Nocopi describes its business model, which combines technology licensing with the sale of proprietary inks and other products to licensees and their authorized printers. These periodic reports typically discuss revenue from license, royalty and fee arrangements, product and other sales, geographic reach through licensees and customers, and risks such as tariff policies and supply chain disruptions.
Investors can also examine Form 8‑K filings, where Nocopi reports material events. Recent 8‑Ks have described stock purchase agreements for private placements of common stock, including the number of shares to be issued, purchase price per share and reliance on exemptions from registration under the Securities Act. Other 8‑Ks have documented board appointments, such as the addition of an independent director affiliated with an investment management firm, and have provided background on the appointee and independence determinations.
This page also surfaces unregistered sales of equity securities disclosures associated with private placements, as well as registration rights agreements that obligate the company to file registration statements for certain shares within specified time frames. Users interested in ownership and governance can use the filings to track changes in the board of directors and senior leadership, as well as compensatory arrangements when disclosed.
Stock Titan enhances these filings with AI‑powered summaries that explain key points in plain language, helping readers understand the implications of lengthy reports and complex transaction terms. Real‑time updates from EDGAR ensure that new Nocopi filings, including 10‑K, 10‑Q, 8‑K and other forms, appear promptly, while AI highlights sections related to capital raises, licensing structures and governance changes so users can focus on the most relevant details.
Nocopi Technologies Inc. director reports no share ownership. A Form 3 filing shows that a reporting person who serves as a director of Nocopi Technologies Inc. (ticker NNUP) has stated they do not beneficially own any non-derivative or derivative securities of the company. The filing is made as an initial statement of beneficial ownership as of the event date of 12/15/2025 and confirms there are no company shares, options, warrants, or other convertible securities currently attributed to this director.
Nocopi Technologies Inc. (NNUP)
Following this grant and related vesting, the reporting person beneficially owns 245,916 shares of Nocopi Technologies common stock in direct ownership. This filing reflects routine equity-based compensation for a senior executive and director rather than an open-market purchase or sale.
Nocopi Technologies Inc. reported insider activity by a director and officer serving as President. On December 29, 2025, the reporting person was granted 20,000 restricted stock units, with 10,000 vesting immediately and the remaining 10,000 scheduled to vest on December 29, 2026. Each unit represents the right to receive one share of Nocopi Technologies common stock.
In a separate transaction on December 31, 2025, the reporting person entered into a Stock Purchase Agreement to buy 33,333 shares of the company’s common stock at $1.50 per share in a private placement. Following these transactions, the filing shows the reporting person directly beneficially owning 200,533 shares of common stock.
Nocopi Technologies Inc. reported an equity compensation award for its Chief Financial Officer. On December 29, 2025, the CFO received 10,000 restricted stock units of Nocopi Technologies common stock. According to the filing, 5,000 units vested immediately on the grant date, while the remaining 5,000 units are scheduled to vest on December 29, 2026.
Following these transactions, the CFO beneficially owned 17,640 shares of common stock after the grant and 15,280 shares after share withholding for taxes. The company withheld 2,360 shares of common stock to satisfy tax obligations arising from the vesting of restricted stock units.
Nocopi Technologies, Inc. disclosed that it entered into Stock Purchase Agreements with institutional investors for a private placement of 266,666 shares of common stock at
In connection with the transaction, Nocopi entered into Registration Rights Agreements requiring it to file a registration statement covering certain purchasers’ placement shares on or prior to January 9, 2027. The shares were sold without registration under the Securities Act in reliance on an exemption for sales to accredited investors.
Nocopi Technologies Inc. reported insider equity activity by its Chief Financial Officer, Debra Glickman. The filing shows that on December 24, 2025, 5,000 shares of common stock were issued to her upon vesting of previously granted restricted stock units, each unit converting into one share of common stock.
On the same date, the company withheld 2,360 shares to cover her tax obligations related to this vesting. After these transactions, Glickman directly beneficially owned 7,640 shares of Nocopi Technologies common stock.
Nocopi Technologies, Inc. reported that its Board of Directors appointed Eric Sites as a Class I Director on December 15, 2025, filling an existing vacancy. He will serve until the Company’s 2028 annual meeting of shareholders and until a successor is elected and qualified, subject to earlier departure events.
Sites is a Vice President at Horizon Kinetics Holding Corp. and serves as a Portfolio Manager and Research Analyst. He has prior board experience at the Canadian Securities Exchange, Bermuda Stock Exchange, Consensus Mining and Seigniorage Company, and Renn Fund, and is currently a Director of IL&FS Securities Services Ltd of India. The Board determined that he is independent under New York Stock Exchange and Nasdaq rules. The Company states there are no appointment-related arrangements, no family relationships with its directors or officers, and no related-party transactions involving Sites requiring disclosure.
Nocopi Technologies (NNUP) filed its Q3 2025 10‑Q, reporting total revenue of $385,800, down from $668,400 a year ago, as lower ink shipments to an authorized printer weighed on product sales. The quarter’s net loss was $26,800 (vs. $251,100), helped by reduced operating expenses; gross profit was $177,500 (46% margin) versus $380,300 (57%). Customer concentration remained high, with Customer A at 63% of Q3 revenue and Customer B at 19%.
For the first nine months of 2025, revenue was $1,224,800 (vs. $1,525,700) with a net loss of $59,900. Operating cash flow was $657,900, lifting cash and equivalents to $11,497,600. Working capital was $12,732,000 and stockholders’ equity $13,673,800 at September 30, 2025. Long‑term receivables tied to license agreements were $924,000. Shares outstanding were 10,814,843 as of November 6, 2025. Management noted continued focus on entertainment and toy markets, with lease terms extended to December 31, 2027.
Phillip Frost and related trust reported an acquisition of common stock in NOCOPI TECHNOLOGIES INC/MD (NNUP). On 09/11/2025 the reporting persons acquired 21,930 shares of common stock as consideration for advisory services under a Stock Purchase Agreement dated September 11, 2023, at a reported price of $0. Following the transaction, Frost Gamma Investments Trust is shown as beneficial owner of 1,489,712 shares on an indirect basis. The filing identifies Phillip Frost, M.D., as a director and 10% owner and disclaims beneficial ownership of the trust shares except to the extent of any pecuniary interest, consistent with the ownership structure described in the exhibit.